Zobrazeno 61 - 70
of 220
pro vyhledávání: '"Nicolaas Schaap"'
Autor:
B. Önfelt, J. S. Hoogstad-van Evert, Esther Wagena, J. M. R. Van der Meer, Joop H. Jansen, Jeannette Cany, P. K. J. D. De Jonge, J. T. Safrit, Peter Friedl, A. B. van der Waart, Willemijn Hobo, J. H. Lee, K. Klarenaar, Leon F.A.G. Massuger, Ralph J. A. Maas, Harry Dolstra, Nicolaas Schaap, K. Guldevall
Publikováno v:
Cancer Immunology, Immunotherapy. 70:3367-3367
Autor:
Holger W. Auner, Marta Krejčí, Nigel H. Russell, Alina Tanase, Curly Morris, David Pohlreich, Paul Browne, Simona Iacobelli, Guido Kobbe, Nicolaas Schaap, Giulia Sbianchi, Wieslaw Wiktor-Jedrzejczak, Stig Lenhoff, Didier Blaise, Jane F. Apperley, Cora Knol-Bout, Esa Jantunen, Achilles Anagnostopoulos, Cecilia Isaksson, Stefan Schönland, Nicolaus Kröger, Ibrahim Yakoub-Agha, Laurent Garderet, Cyrille Touzeau, Christof Scheid
Publikováno v:
Haematologica. 103:514-521
Melphalan at a dose of 200 mg/m2 is standard conditioning prior to autologous hematopoietic stem cell transplantation for multiple myeloma, but a dose of 140 mg/m2 is often used in clinical practice in patients perceived to be at risk of excess toxic
Autor:
Avichai Shimoni, Mark Ringhoffer, Gülsan Türköz Sucak, Herve Finel, Gwendolyn Van Gorkom, Sebastian Giebel, Nicolaas Schaap, David Pohlreich, Peter Dreger, Anna Sureda, Harry C. Schouten
Publikováno v:
Journal of Clinical Apheresis, 32(5), 295-301. Wiley
Journal of Clinical Apheresis, 32, 295-301
Journal of Clinical Apheresis, 32, 5, pp. 295-301
Journal of Clinical Apheresis, 32, 295-301
Journal of Clinical Apheresis, 32, 5, pp. 295-301
Item does not contain fulltext High-dose chemotherapy followed by autologous stem cell transplantation (ASCT) to rescue hematopoiesis is considered standard care for patients with a relapsed chemosensitive lymphoma, but diagnosis of lymphoma has been
Autor:
Dietrich W. Beelen, Montserrat Rovira, Arnon Nagler, Tobias Gedde-Dahl, Johanna Waidhauser, Nicolaus Kröger, Gwendolyn Van Gorkom, Jürgen Finke, Christoph Schmid, Myriam Labopin, Eefke Petersen, Jordi Esteve, Nicolaas Schaap, Mohamad Mohty, Donald Bunjes, Jan J. Cornelissen
Publikováno v:
Web of Science
Introduction Acute myeloid leukemia bearing a RUNX1 gene mutation (RUNX1+ AML) has been proposed as a provisional entity in the 2016 WHO classification. Clinically, it has been associated with inferior response rates and outcome after conventional ch
Autor:
Arnon Nagler, Donald Bunjes, Mohamad Mohty, Jürgen Kuball, Stephane Vigouroux, Dietger Niederwieser, Avichai Shimoni, Liisa Volin, Bipin N. Savani, Hendrik Veelken, Jorge Sierra, Gerhard Ehninger, Matthias Eder, Nicolaas Schaap, Andrea Bacigalupo, Myriam Labopin
Publikováno v:
Journal of Hematology & Oncology, Vol 9, Iss 1, Pp 1-10 (2016)
Journal of hematology & oncology, 9. BioMed Central
Journal of Hematology and Oncology, 9
Journal of Hematology & Oncology, 9, 1, pp. 118
Journal of Hematology & Oncology
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Journal of Hematology & Oncology, 9, 118
Journal of hematology & oncology, 9. BioMed Central
Journal of Hematology and Oncology, 9
Journal of Hematology & Oncology, 9, 1, pp. 118
Journal of Hematology & Oncology
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Journal of Hematology & Oncology, 9, 118
Background Myeloablative (MAC) and reduced-intensity conditioning (RIC) are established approaches for allogeneic stem cell transplantation (SCT) in acute myeloid leukemia (AML). Most deaths after MAC occur within the first 2 years after SCT, while p
Autor:
Joop H. Jansen, Rob Woestenenk, Lex B. H. Bakker, Tim J. A. Hutten, Willemijn Hobo, Ben Joosten, Nicolaas Schaap, Hanny Fredrix, Harry Dolstra, Alessandra Cambi, Jurjen Tel, Soley Thordardottir, Gerben M. Franssen, Lisanne M. A. Janssen, Otto C. Boerman, Mirjam H.M. Heemskerk
Publikováno v:
Journal of Immunology, 197, 7, pp. 2715-25
Journal of Immunology, 197, 2715-25
Journal of Immunology, 197(7), 2715-2725
Journal of Immunology, 197, 2715-25
Journal of Immunology, 197(7), 2715-2725
Contains fulltext : 172057.pdf (Publisher’s version ) (Closed access) Potent immunotherapies are urgently needed to boost antitumor immunity and control disease in cancer patients. As dendritic cells (DCs) are the most powerful APCs, they are an at
Autor:
Paolo Bartolomeo, Tsila Zuckerman, Liisa Volin, Peter Brossart, Yener Koc, Donal P. McLornan, Jakob Passweg, Per Ljungman, Nicolaus Kröger, Dominik Wolf, Liesbeth C. de Wreede, Fabio Ciceri, Stefania Bregante, Kavita Raj, Kristina Carlson, Ibrahim Yakoub-Agha, Didier Blaise, Antonin Vitek, Eduardo Olavarria, Henric Jan Blok, José Luis Díez-Martín, Marie Robin, Nicolaas Schaap, Yves Chalandon, Diderik Jan Eikema
Publikováno v:
Biology of Blood and Marrow Transplantation, 25(3), 522-528
Biology of Blood and Marrow Transplantation, 25, 3, pp. 522-528
Biology of Blood and Marrow Transplantation, 25, 522-528
Biology of Blood and Marrow Transplantation, 25, 3, pp. 522-528
Biology of Blood and Marrow Transplantation, 25, 522-528
Contains fulltext : 202803.pdf (Publisher’s version ) (Open Access) This analysis included 56 myelofibrosis (MF) patients transplanted from family mismatched donor between 2009 and 2015 enrolled in the European Society for Blood and Marrow Transpla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c769b114d2794b9899ab8977d6a0c289
http://hdl.handle.net/1887/121452
http://hdl.handle.net/1887/121452
Autor:
Sabine Gerull, Giorgia Battipaglia, Arnon Nagler, Johan Maertens, Patrice Chevallier, William Arcese, Jan J. Cornelissen, Mohamad Mohty, Azedine Djabali, Didier Blaise, Ali Bazarbachi, Joerg Halter, Jean El-Cheikh, Gérard Socié, Nicolaas Schaap, Edouard Forcade, Myriam Labopin, Jordi Esteve
Publikováno v:
Clinical Hematology International, Vol 1, Iss 1 (2019)
Acute myeloid leukemia (AML) with FLT3-mutation carries a poor prognosis, and allogeneic stem cell transplantation (allo-SCT) is recommended at first complete remission (CR1). We assessed 462 adults (median age 50 years) with FLT3-mutated AML allogra
Autor:
Georg A. Böhmig, Morton J. Cowan, Nicolaas Schaap, Cyril Garrouste, E.M. Dauber, Søren Schwartz Sørensen, Michael Eder, Michael Kammer, Hideki Ishida, Anette Bachmann, Ulrich A. Duffner, Christoph Schwarz, Gabriela A. Berlakovich, Tepsiri Chongkrairatanakul, Sergio Alvarez, Thomas Wekerle, Rommel Ravanan, Niels Jacobsen, Michael Medinger, Heinz Regele, Martina Koch, Rainer Oberbauer, Robert S. Gaston, Brett Cullis, Masouridi Levrat Stavroula
Publikováno v:
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, vol 19, iss 2
American Journal of Transplantation
Eder, M, Schwarz, C, Kammer, M, Jacobsen, N, Stavroula, M L, Cowan, M J, Chongkrairatanakul, T, Gaston, R, Ravanan, R, Ishida, H, Bachmann, A, Alvarez, S, Koch, M, Garrouste, C, Duffner, U A, Cullis, B, Schaap, N, Medinger, M, Sørensen, S S, Dauber, E-M, Böhmig, G, Regele, H, Berlakovich, G A, Wekerle, T & Oberbauer, R 2019, ' Allograft and patient survival after sequential HSCT and kidney transplantation from the same donor-A multicenter analysis ', American Journal of Transplantation, vol. 19, no. 2, pp. 475-487 . https://doi.org/10.1111/ajt.14970
American Journal of Transplantation, 19, 475-487
American Journal of Transplantation, 19, 2, pp. 475-487
American Journal of Transplantation
Eder, M, Schwarz, C, Kammer, M, Jacobsen, N, Stavroula, M L, Cowan, M J, Chongkrairatanakul, T, Gaston, R, Ravanan, R, Ishida, H, Bachmann, A, Alvarez, S, Koch, M, Garrouste, C, Duffner, U A, Cullis, B, Schaap, N, Medinger, M, Sørensen, S S, Dauber, E-M, Böhmig, G, Regele, H, Berlakovich, G A, Wekerle, T & Oberbauer, R 2019, ' Allograft and patient survival after sequential HSCT and kidney transplantation from the same donor-A multicenter analysis ', American Journal of Transplantation, vol. 19, no. 2, pp. 475-487 . https://doi.org/10.1111/ajt.14970
American Journal of Transplantation, 19, 475-487
American Journal of Transplantation, 19, 2, pp. 475-487
Tolerance induction through simultaneous hematopoietic stem cell and renal transplantation has shown promising results, but it is hampered by the toxicity of preconditioning therapies and graft‐versus‐host disease (GVHD). Moreover, renal function
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3dc32622bc53d90ab112f3590d70c0f
https://escholarship.org/uc/item/0f16n45s
https://escholarship.org/uc/item/0f16n45s
Autor:
Rebecca Wijers, Cor H. J. Lamers, Eefke Petersen, Burak Kalin, Nicolaas Schaap, Mariëtte N. D. Ter Borg, Eric Braakman, Cornelis A.M. van Bergen, Jan J. Cornelissen, J.H. Frederik Falkenburg, Sacha Zeerleder, Annoek E.C. Broers, Bronno van der Holt, Judith A.E. Somers, Jürgen Kuball, Ellen Meijer
Publikováno v:
HemaSphere, 3(5)
HemaSphere
HemaSphere, 3(5):e285. Wolters Kluwer Health
HemaSphere, 3(5):UNSP e285. Wolters Kluwer Health
HemaSphere, Vol 3, Iss 5 (2019)
Kalin, B, Ter Borg, M, Wijers, R, Somers, J A E, Van Der Holt, B, Van Bergen, C A M, Petersen, E J, Kuball, J, Meijer, E, Schaap, N P M, Zeerleder, S S, Broers, A E, Braakman, E, Frederik Falkenburg, J H, Lamers, C H J & Cornelissen, J J 2019, ' Double Umbilical Cord Blood Transplantation in High-Risk Hematological Patients : A Phase II Study Focusing on the Mechanism of Graft Predominance ', HemaSphere, vol. 3, no. 5, e285 . https://doi.org/10.1097/HS9.0000000000000285
HemaSphere
HemaSphere, 3(5):e285. Wolters Kluwer Health
HemaSphere, 3(5):UNSP e285. Wolters Kluwer Health
HemaSphere, Vol 3, Iss 5 (2019)
Kalin, B, Ter Borg, M, Wijers, R, Somers, J A E, Van Der Holt, B, Van Bergen, C A M, Petersen, E J, Kuball, J, Meijer, E, Schaap, N P M, Zeerleder, S S, Broers, A E, Braakman, E, Frederik Falkenburg, J H, Lamers, C H J & Cornelissen, J J 2019, ' Double Umbilical Cord Blood Transplantation in High-Risk Hematological Patients : A Phase II Study Focusing on the Mechanism of Graft Predominance ', HemaSphere, vol. 3, no. 5, e285 . https://doi.org/10.1097/HS9.0000000000000285